Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated human chorionic gonadotropin (hCG) priming before controlled ovarian hyperstimulation in poor-responder IVF patients and has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • human chorionic gonadotropin (hCG) (human chorionic gonadotropin)

Snippet

Sponsor: IVI Madrid | Conditions: Ovarian Response | Phase 4 | Status: COMPLETED